2026-04-17T04:07:50Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1777882025-12-04T19:22:13Zcom_2072_1057col_2072_478858col_2072_478916col_2072_478917

00925njm 22002777a 4500 dc Jiménez, Sònia author Miró i Andreu, Òscar author Llorens, Pere author Martín Sánchez, Francisco Javier author Burillo Putze, Guillermo author Piñera, Pascual author Martín, Alfonso author Alquézar Arbé, Aitor author García Lamberechts, Eric Jorge author Jacob, Javier author Grima, María L. L. author Millán, Javier author Molina, Francisca author Albero, Patricia B. author Cardozo, Carlos author Mòdol, Josep M. author Aguirre, Alfons author Gaya, Ruth author Adroher, María author Llauger, Lluís author Díaz, Juan J. L. author González, Nayra C. author Aragües, Paula L. author Gómez, Ana P. author Castillo, Juan G. del author TeAm (SIESTA) network author 2021-05-28T10:13:33Z 2021-05-28T10:13:33Z 2021-03-02 2021-05-28T06:24:26Z Background and importance: A higher incidence of venous thromboembolism [both pulmonary embolism and deep vein thrombosis (DVT)] in patients with coronavirus disease 2019 (COVID-19) has been described. But little is known about the true frequency of DVT in patients who attend emergency department (ED) and are diagnosed with COVID-19. Objective: We investigated the incidence, risk factors, clinical characteristics and outcomes of DVT in patients with COVID-19 attending the ED before hospitalization. Methods: We retrospectively reviewed all COVID patients diagnosed with DVT in 62 Spanish EDs (20% of Spanish EDs, case group) during the first 2 months of the COVID-19 outbreak. We compared DVT-COVID-19 patients with COVID-19 without DVT patients (control group). Relative frequencies of DVT were estimated in COVID and non-COVID patients visiting the ED and annual standardized incidences were estimated for both populations. Sixty-three patient characteristics and four outcomes were compared between cases and controls. Results: We identified 112 DVT in 74 814 patients with COVID-19 attending the ED [1.50‰; 95% confidence interval (CI), 1.23-1.80‰]. This relative frequency was similar than that observed in non-COVID patients [2109/1 388 879; 1.52‰; 95% CI, 1.45-1.69‰; odds ratio (OR) = 0.98 [0.82-1.19]. Standardized incidence of DVT was higher in COVID patients (98,38 versus 42,93/100,000/year; OR, 2.20; 95% CI, 2.03-2.38). In COVID patients, the clinical characteristics associated with a higher risk of presenting DVT were older age and having a history of venous thromboembolism, recent surgery/immobilization and hypertension; chest pain and desaturation at ED arrival and some analytical disturbances were also more frequently seen, d-dimer >5000 ng/mL being the strongest. After adjustment for age and sex, hospitalization, ICU admission and prolonged hospitalization were more frequent in cases than controls, whereas mortality was similar (OR, 1.37; 95% CI, 0.77-2.45). Conclusions: DVT was an unusual form of COVID presentation in COVID patients but was associated with a worse prognosis. COVID-19 Tromboembolisme COVID-19 Thromboembolism Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8